Floatz logo

Ganciclovir

Chronic Phase Chronic Myelogenous Leukemia

City of Hope Medical CenterSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

85 Active assets in the Chronic Phase Chronic Myelogenous Leukemia cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
City of Hope Medical Center
Phase 3BBB
Nilotinib
Novartis Pharmaceuticals
Phase 4BBB
Fludarabine
Fred Hutchinson Cancer Center
Phase 3BBB
METHOTREXATE
M.D. Anderson Cancer Center
Phase 3BBB
Sargramostim
Virginia Commonwealth University
Phase 2BBB

View all 50 →

Same molecule, other indications

Ganciclovir is also rated in:

cytomegalovirus retinitisDormant
A
Indicative ·
82 / 100
View asset →
HIV infectious diseaseDormant
BBB
Indicative ·
76 / 100
View asset →
cytomegalovirus infectionDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →